Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.34M | -8.36M | -9.46M | -9.46M | -9.64M |
| Total Depreciation and Amortization | 31.70K | 35.40K | 39.40K | 43.40K | 48.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.38M | 1.33M | 1.28M | 1.12M | 985.10K |
| Change in Net Operating Assets | -1.68M | -2.05M | -2.42M | -239.90K | 1.86M |
| Cash from Operations | -7.61M | -9.05M | -10.56M | -8.54M | -6.75M |
| Capital Expenditure | -8.30K | -9.70K | -11.10K | -7.80K | -4.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.64M | -9.37M | -2.04M | 2.78M | 7.45M |
| Cash from Investing | -16.64M | -9.38M | -2.06M | 2.78M | 7.44M |
| Total Debt Issued | 7.50M | 7.50M | 7.50M | 3.75M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.79M | 8.88M | 2.98M | 1.62M | 270.80K |
| Cash from Financing | 25.24M | 18.36M | 11.46M | 5.66M | 292.80K |
| Foreign Exchange rate Adjustments | 77.00K | 72.70K | 68.30K | 20.10K | -25.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.06M | -300.00 | -1.09M | -82.40K | 959.70K |